Viatcheslav Rakov
Corporate Officer/Principal at Myovant Sciences GmbH
Network origin in Viatcheslav Rakov first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Myovant Sciences GmbH
 Myovant Sciences GmbH BiotechnologyHealth Technology Myovant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company is headquartered in Basel, Switzerland.
2
| Subsidiary | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Viatcheslav Rakov via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member | |
| University of Missouri | College/University | Doctorate Degree | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IMMATICS N.V. | Biotechnology | Director/Board Member | |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| XENCOR, INC. | Biotechnology | Corporate Officer/Principal |
Statistics
International
| United States | 6 |
| United Kingdom | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Nancy Valente | 8 |
| Elke Hunsche | 1 |
- Stock Market
- Insiders
- Viatcheslav Rakov
- Company connections
